| Literature DB >> 28683304 |
Kristen Therese Thomas1, Bart Russell Anderson1, Niraj Shah1, Stephanie Elaine Zimmer1, Daniel Hawkins1, Arielle Nicole Valdez1, Qiaochu Gu1, Gary Jonathan Bassell2.
Abstract
Genomic studies have repeatedly associated variants in the gene encoding the microRNA miR-137 with increased schizophrenia risk. Bioinformatic predictions suggest that miR-137 regulates schizophrenia-associated signaling pathways critical to neural development, but these predictions remain largely unvalidated. In the present study, we demonstrate that miR-137 regulates neuronal levels of p55γ, PTEN, Akt2, GSK3β, mTOR, and rictor. All are key proteins within the PI3K-Akt-mTOR pathway and act downstream of neuregulin (Nrg)/ErbB and BDNF signaling. Inhibition of miR-137 ablates Nrg1α-induced increases in dendritic protein synthesis, phosphorylated S6, AMPA receptor subunits, and outgrowth. Inhibition of miR-137 also blocks mTORC1-dependent responses to BDNF, including increased mRNA translation and dendritic outgrowth, while leaving mTORC1-independent S6 phosphorylation intact. We conclude that miR-137 regulates neuronal responses to Nrg1α and BDNF through convergent mechanisms, which might contribute to schizophrenia risk by altering neural development.Entities:
Keywords: AMPAR; BDNF; mTOR; miR-137; neuregulin; schizophrenia
Mesh:
Substances:
Year: 2017 PMID: 28683304 PMCID: PMC5745041 DOI: 10.1016/j.celrep.2017.06.038
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423